Lidotran
Lidotran is an FDA drug label for the active ingredient LIDOCAINE HYDROCHLORIDE manufactured by PureTek Corporation administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220919.
Generic: LIDOCAINE HYDROCHLORIDE
Manufacturer: PureTek Corporation
Product Type: HUMAN PRESCRIPTION DRUG
Route: TOPICAL
Dosage Form:
NDC: 59088-483
Application:
Effective: 20220919
Indications & Usage
INDICATIONS For the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritation.
Dosage & Administration
DOSAGE AND ADMINISTRATION Apply a thin film to the affected area two or three times daily or as directed by a physician.
Contraindications
CONTRAINDICATIONS Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Warnings
WARNINGS For external use only. Not for ophthalmic use.
Adverse Reactions
ADVERSE REACTIONS During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
More from same ingredient
ADVANCED NUMB Topical Anesthetic
Uber Scientific, LLC
Accucaine
Asclemed USA, Inc.
Assured
Zhejiang Jingwei Pharmaceutical Co., Ltd.
Bactine Max Dry
WellSpring Pharmaceutical Corporation
DOCTORS TOUCH Erase The Pain Lidocaine
DOCTOR'S CHOICE MEDICAL, LLC
DermacinRx Lidotral
PureTek Corporation
EBSL-5
Water-Jel Technologies
EBSS-5
Water-Jel Technologies